Skip to content

Author

Yasen Mijiti

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Beyond hepatoprotection: a meta-analysis quantifying the cardiovascular benefit of antidiabetic drugs in patients with metabolic dysfunction-associated steatohepatitis

Metabolic dysfunction-associated steatohepatitis (MASH), the progressive form of metabolic dysfunction-associated steatotic liver disease (MASLD), is associated with substantially elevated cardiovascular risk, yet the cardiovascular efficacy of antidiabetic drugs in this population has not been systematically quant...

Najeeb Ullah, Yasen Mijiti, Guo-Li Du · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.